ENDUR ACIN Wax Matrix Niacin Research STUDIES

Highlights Stepped-care, multi-drug therapy shows clinical benefits in patients with established CHD Therapeutic options include pravastatin, ENDUR-ACIN®, cholestyramine and gemfibrozil Combining ENDUR-ACIN® with pravastatin adds significant benefits for improving LDL...

Highlights ENDUR-ACIN® treatment (1,500-2,000 mg/day) significantly reduces total and LDL-cholesterol in people with high blood cholesterol (>225 mg/dl). Low dropout rate or 4.5% (4/89), primarily due to skin flushing or...

Highlights Effective niacin therapy (2 g/day) can be inexpensive ($7-10/month) “No-flush” inositol hexaniacinate products fail to contain free nicotinic acid, yet are comparatively expensive ($22/month) “No-flush” inositol hexaniacinate is an...

Highlights ENDUR-ACIN® is an effective treatment for hyperlipidemia in patients with ischemic heart disease, especially if fibrates are contraindicated. Summary This comparison study explores the relative efficacy of long-term use...

Highlights ENDUR-ACIN® significantly improves blood lipids in patients with dyslipidemia Effective dosage range is 1,500 to 2,000 mg/day Mean LDL cholesterol reduction in the range of 16-21% Good safety profile...